ID   FIMW_PSEAE              Reviewed;         607 AA.
AC   Q9HUK7;
DT   10-APR-2019, integrated into UniProtKB/Swiss-Prot.
DT   10-APR-2019, sequence version 2.
DT   07-APR-2021, entry version 74.
DE   RecName: Full=Cyclic-di-GMP receptor FimW {ECO:0000303|PubMed:30581112};
GN   Name=fimW {ECO:0000303|PubMed:30581112};
GN   OrderedLocusNames=PA4958 {ECO:0000312|EMBL:AAG08343.1};
OS   Pseudomonas aeruginosa (strain ATCC 15692 / DSM 22644 / CIP 104116 / JCM
OS   14847 / LMG 12228 / 1C / PRS 101 / PAO1).
OC   Bacteria; Proteobacteria; Gammaproteobacteria; Pseudomonadales;
OC   Pseudomonadaceae; Pseudomonas.
OX   NCBI_TaxID=208964;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC   STRAIN=ATCC 15692 / DSM 22644 / CIP 104116 / JCM 14847 / LMG 12228 / 1C /
RC   PRS 101 / PAO1;
RX   PubMed=10984043; DOI=10.1038/35023079;
RA   Stover C.K., Pham X.-Q.T., Erwin A.L., Mizoguchi S.D., Warrener P.,
RA   Hickey M.J., Brinkman F.S.L., Hufnagle W.O., Kowalik D.J., Lagrou M.,
RA   Garber R.L., Goltry L., Tolentino E., Westbrock-Wadman S., Yuan Y.,
RA   Brody L.L., Coulter S.N., Folger K.R., Kas A., Larbig K., Lim R.M.,
RA   Smith K.A., Spencer D.H., Wong G.K.-S., Wu Z., Paulsen I.T., Reizer J.,
RA   Saier M.H. Jr., Hancock R.E.W., Lory S., Olson M.V.;
RT   "Complete genome sequence of Pseudomonas aeruginosa PAO1, an opportunistic
RT   pathogen.";
RL   Nature 406:959-964(2000).
RN   [2]
RP   FUNCTION, SUBUNIT, SUBCELLULAR LOCATION, DOMAIN, DISRUPTION PHENOTYPE, AND
RP   MUTAGENESIS OF ARG-324; ARG-328; SER-437 AND GLY-440.
RC   STRAIN=ATCC 15692 / DSM 22644 / CIP 104116 / JCM 14847 / LMG 12228 / 1C /
RC   PRS 101 / PAO1;
RX   PubMed=30581112; DOI=10.1016/j.chom.2018.11.008;
RA   Laventie B.J., Sangermani M., Estermann F., Manfredi P., Planes R., Hug I.,
RA   Jaeger T., Meunier E., Broz P., Jenal U.;
RT   "A surface-induced asymmetric program promotes tissue colonization by
RT   Pseudomonas aeruginosa.";
RL   Cell Host Microbe 25:140-152(2019).
CC   -!- FUNCTION: High-affinity cyclic-di-GMP binding protein that regulates
CC       type IV pili (T4P) elongation. Required for T4P-mediated surface
CC       attachment and walking motility during the early phases of surface
CC       colonization. Not required for twitching motility. Does not bind
CC       related nucleotides such as GMP, GDP, GTP or ATP.
CC       {ECO:0000269|PubMed:30581112}.
CC   -!- SUBUNIT: Monomer in the absence of c-di-GMP. Forms dimers in the
CC       presence of c-di-GMP. {ECO:0000269|PubMed:30581112}.
CC   -!- SUBCELLULAR LOCATION: Cytoplasm. Note=Rapidly localizes to the cell
CC       poles upon surface contact in a c-di-GMP-dependent manner. Dynamically
CC       transitions between the cytoplasm and the cell poles, as a function of
CC       c-di-GMP binding. {ECO:0000269|PubMed:30581112}.
CC   -!- DOMAIN: Contains a PilZ-like fold that binds two molecules of c-di-GMP
CC       via two well-conserved c-di-GMP-binding motifs, RXXXR and D/NXSXXG.
CC       {ECO:0000269|PubMed:30581112}.
CC   -!- DISRUPTION PHENOTYPE: Mutant has reduced surface piliation and is
CC       unable to increase piliation upon surface exposure. It shows defects in
CC       initial surface attachment and in early biofilm formation, but late
CC       biofilm formation is not affected. Mutant loses walking motility but
CC       twitching motility is barely affected. {ECO:0000269|PubMed:30581112}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=AAG08343.1; Type=Erroneous initiation; Note=Truncated N-terminus.; Evidence={ECO:0000305|PubMed:30581112};
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AE004091; AAG08343.1; ALT_INIT; Genomic_DNA.
DR   PIR; D83027; D83027.
DR   RefSeq; NP_253645.1; NC_002516.2.
DR   RefSeq; WP_003113922.1; NZ_QZGE01000002.1.
DR   PaxDb; Q9HUK7; -.
DR   PRIDE; Q9HUK7; -.
DR   EnsemblBacteria; AAG08343; AAG08343; PA4958.
DR   GeneID; 878415; -.
DR   KEGG; pae:PA4958; -.
DR   PATRIC; fig|208964.12.peg.5192; -.
DR   PseudoCAP; PA4958; -.
DR   HOGENOM; CLU_031627_1_0_6; -.
DR   OMA; HSPGGYC; -.
DR   BioCyc; PAER208964:G1FZ6-5074-MONOMER; -.
DR   Proteomes; UP000002438; Chromosome.
DR   GO; GO:0005737; C:cytoplasm; IEA:UniProtKB-SubCell.
DR   GO; GO:0000166; F:nucleotide binding; IEA:UniProtKB-KW.
DR   GO; GO:0009405; P:pathogenesis; IEA:UniProtKB-KW.
PE   1: Evidence at protein level;
KW   c-di-GMP; Cytoplasm; Nucleotide-binding; Reference proteome; Virulence.
FT   CHAIN           1..607
FT                   /note="Cyclic-di-GMP receptor FimW"
FT                   /id="PRO_0000446520"
FT   REGION          323..492
FT                   /note="PilZ-like domain"
FT                   /evidence="ECO:0000305|PubMed:30581112"
FT   MOTIF           324..328
FT                   /note="RXXXR motif"
FT                   /evidence="ECO:0000305|PubMed:30581112"
FT   MOTIF           435..440
FT                   /note="D/NXSXXG motif"
FT                   /evidence="ECO:0000305|PubMed:30581112"
FT   MUTAGEN         324
FT                   /note="R->A: 5.6-fold decrease in c-di-GMP affinity."
FT                   /evidence="ECO:0000269|PubMed:30581112"
FT   MUTAGEN         328
FT                   /note="R->A: Cannot bind c-di-GMP. Fails to localize to the
FT                   poles and to attach to the surface."
FT                   /evidence="ECO:0000269|PubMed:30581112"
FT   MUTAGEN         437
FT                   /note="S->A: 9.3-fold decrease in c-di-GMP affinity."
FT                   /evidence="ECO:0000269|PubMed:30581112"
FT   MUTAGEN         440
FT                   /note="G->A: Cannot bind c-di-GMP."
FT                   /evidence="ECO:0000269|PubMed:30581112"
SQ   SEQUENCE   607 AA;  67829 MW;  C1A1B553D1D66882 CRC64;
     MENQSPHLSL RVPTPTQQNL SFCDATPKDI KYWLAHLPKA NLGETARQLY QGLIELNQLV
     LPVEARLQLL ELFRPEVHFV CAHLERHFLN QAIVLDERPR KIANLCQALQ NHLAIGYKLI
     VVQEAPRNSR DRAQLFAVGI QRAIRSLCGP LIRASQLYCP VPEGLWLELH QLYQLASQRG
     VHRLAVRDEL AKHTPGLSVE QAYLIPLLLG CARCNQMRQN NIARLAEVLE PWSQLLSIQS
     ATLPGSLFIA VPQIDGPPRY RSLYPETQLA SALGIDTQPL VELIREYLLQ PEAERAKARL
     PLIEGVTLDL LQHLSSAWGD IAERTFQRTQ GQGQLTLCIG MSALHYFLAG RRPFNEVLQI
     QEAPEAPRFK ADVQDAWAGA FDAQKVTDWQ PGMPLEEIEY RPHQSPRSVQ PGHPQAHAQA
     DATEDYPTYA LPIVNHSPGG YCLSWPKEVP AQLQAGELVG LQDLPGQAWS IAVVRWIRQV
     RNGGTQMGIE MIAPAAQPCG LQLLRKTEQS SHYLRALLLP AIAAISRPAT VITPRLPFQE
     GSRVQINLHG EERRAVLNRR QASTGSFSQF EYRSAEPVNT PSDKPVTAPV ARPPAGEEDF
     DSLWKSL
//
